Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Taizo Nakano

Concepts (191)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anemia, Aplastic
11
2026
42
2.490
Why?
Purpura, Thrombocytopenic, Idiopathic
4
2026
18
1.520
Why?
Myelodysplastic Syndromes
3
2021
170
1.250
Why?
Bone Marrow Diseases
3
2023
20
0.990
Why?
Kasabach-Merritt Syndrome
2
2023
8
0.920
Why?
Hematologic Diseases
2
2023
66
0.920
Why?
Pancytopenia
1
2023
7
0.770
Why?
Chylous Ascites
1
2022
5
0.740
Why?
Chylothorax
1
2022
20
0.730
Why?
Noonan Syndrome
1
2022
14
0.720
Why?
Respiration Disorders
1
2022
78
0.700
Why?
Leukemia, Myeloid, Acute
3
2022
700
0.620
Why?
Lymphohistiocytosis, Hemophagocytic
3
2026
33
0.580
Why?
Hematopoietic Stem Cell Transplantation
3
2024
700
0.540
Why?
Child
28
2026
22638
0.500
Why?
Practice Patterns, Physicians'
2
2026
1370
0.450
Why?
Benzoates
2
2025
48
0.450
Why?
Hydrazines
2
2025
37
0.450
Why?
Decision Making
1
2020
987
0.370
Why?
Lymphatic Abnormalities
2
2025
20
0.360
Why?
Sialic Acids
1
2011
8
0.350
Why?
Pyrazoles
2
2025
516
0.340
Why?
Antineoplastic Agents
1
2022
2218
0.320
Why?
Child, Preschool
18
2026
11888
0.300
Why?
Immunosuppressive Agents
3
2025
824
0.300
Why?
Antibodies, Monoclonal, Humanized
2
2026
992
0.290
Why?
Humans
39
2026
145625
0.280
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2012
299
0.280
Why?
Antibodies, Monoclonal
2
2026
1511
0.270
Why?
Anemia, Hemolytic, Autoimmune
1
2026
16
0.240
Why?
MDS1 and EVI1 Complex Locus Protein
2
2023
8
0.240
Why?
Immune System Diseases
1
2026
42
0.240
Why?
Receptors, Thrombopoietin
1
2025
6
0.230
Why?
Polyarteritis Nodosa
1
2025
11
0.230
Why?
Severe Combined Immunodeficiency
1
2025
22
0.230
Why?
Infant
14
2026
10093
0.230
Why?
Adenosine Deaminase
1
2025
45
0.220
Why?
Gene Expression Regulation, Neoplastic
1
2011
1429
0.220
Why?
Mitogen-Activated Protein Kinase Kinases
2
2023
126
0.220
Why?
Antibodies, Antiphospholipid
1
2024
29
0.210
Why?
Adolescent
16
2026
22451
0.210
Why?
Intercellular Signaling Peptides and Proteins
1
2025
372
0.200
Why?
Hemangioendothelioma
1
2023
13
0.200
Why?
Arthritis, Juvenile
1
2024
64
0.200
Why?
Disease Management
2
2026
649
0.200
Why?
Vascular Neoplasms
1
2023
19
0.200
Why?
Hemangioma
1
2023
46
0.200
Why?
Rheumatic Diseases
1
2024
101
0.190
Why?
Neoplasms
2
2026
2944
0.190
Why?
Sarcoma, Kaposi
1
2023
82
0.190
Why?
Proto-Oncogenes
1
2022
27
0.180
Why?
Cyclosporine
2
2025
256
0.180
Why?
Wnt Signaling Pathway
1
2024
211
0.180
Why?
Fanconi Anemia
1
2022
11
0.180
Why?
Venous Thrombosis
1
2024
195
0.180
Why?
Terminology as Topic
1
2024
253
0.180
Why?
Ascites
1
2022
47
0.180
Why?
Syndrome
1
2023
377
0.180
Why?
Proto-Oncogene Proteins p21(ras)
1
2023
250
0.180
Why?
Exocrine Pancreatic Insufficiency
1
2022
25
0.180
Why?
Guideline Adherence
1
2026
585
0.170
Why?
Pyrimidinones
1
2022
124
0.170
Why?
Drainage
1
2022
187
0.170
Why?
Genetic Counseling
1
2021
82
0.160
Why?
Bone Marrow Transplantation
2
2020
298
0.160
Why?
Hepatitis
1
2021
43
0.160
Why?
Retrospective Studies
10
2026
17291
0.160
Why?
Pyridones
1
2022
210
0.160
Why?
Young Adult
10
2026
14240
0.150
Why?
Prognosis
4
2020
4331
0.150
Why?
Antilymphocyte Serum
1
2019
55
0.140
Why?
Hematopoietic System
1
2018
7
0.140
Why?
Communication
1
2025
979
0.140
Why?
Female
20
2026
79080
0.140
Why?
Male
20
2026
73014
0.140
Why?
Treatment Outcome
8
2026
11744
0.140
Why?
Sclerotherapy
1
2018
18
0.140
Why?
Histiocytosis, Langerhans-Cell
1
2018
36
0.140
Why?
Survival Rate
2
2020
2078
0.140
Why?
Metformin
1
2022
328
0.140
Why?
Zebrafish
1
2023
533
0.140
Why?
Doxycycline
1
2018
61
0.140
Why?
Transcription Factors
2
2023
1728
0.130
Why?
Time-to-Treatment
1
2020
257
0.130
Why?
Liver Transplantation
1
2024
699
0.130
Why?
Genome-Wide Association Study
1
2024
1526
0.130
Why?
Electronic Health Records
1
2025
1208
0.130
Why?
Secondary Prevention
1
2018
247
0.120
Why?
Parents
1
2025
1393
0.120
Why?
Spleen
1
2018
503
0.120
Why?
Skin Neoplasms
1
2023
805
0.120
Why?
Adult
12
2026
40821
0.120
Why?
Patient Selection
1
2020
720
0.120
Why?
Surveys and Questionnaires
3
2026
6050
0.110
Why?
Immunoglobulins, Intravenous
2
2026
134
0.110
Why?
Phenotype
1
2023
3186
0.110
Why?
North America
2
2026
299
0.100
Why?
Antibodies, Neutralizing
2
2026
346
0.090
Why?
Receptors, Antigen, T-Cell
1
2016
676
0.090
Why?
Hyperbilirubinemia
1
2012
11
0.090
Why?
Sialyltransferases
1
2011
13
0.090
Why?
Induction Chemotherapy
1
2012
87
0.090
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
96
0.080
Why?
Anemia, Hemolytic, Congenital
1
2011
1
0.080
Why?
Porphyria, Erythropoietic
1
2011
2
0.080
Why?
Organ Specificity
1
2011
306
0.080
Why?
Pancreatitis
1
2012
146
0.080
Why?
Interdisciplinary Communication
1
2012
200
0.080
Why?
Chemical and Drug Induced Liver Injury
1
2012
138
0.080
Why?
HLA Antigens
2
2022
241
0.080
Why?
Inflammation
1
2022
2915
0.080
Why?
Evidence-Based Medicine
2
2024
727
0.080
Why?
Liver
1
2018
1859
0.080
Why?
Follow-Up Studies
4
2020
5397
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2019
1996
0.080
Why?
Neoplasm Proteins
1
2011
443
0.070
Why?
Recurrence
2
2024
1125
0.070
Why?
Severity of Illness Index
3
2025
2910
0.070
Why?
Hyperglycemia
1
2012
381
0.070
Why?
T-Lymphocytes
1
2016
2007
0.070
Why?
Pilot Projects
2
2025
1878
0.060
Why?
Practice Guidelines as Topic
2
2026
1581
0.060
Why?
Combined Modality Therapy
2
2020
1269
0.060
Why?
Rho(D) Immune Globulin
1
2025
6
0.060
Why?
Patient Care Team
1
2012
700
0.060
Why?
Agammaglobulinemia
1
2025
36
0.060
Why?
Platelet Count
1
2025
94
0.060
Why?
Still's Disease, Adult-Onset
1
2024
5
0.050
Why?
Thrombocytopenia
1
2026
205
0.050
Why?
Antiphospholipid Syndrome
1
2024
37
0.050
Why?
Mutation, Missense
1
2025
331
0.050
Why?
Middle Aged
5
2025
36359
0.050
Why?
Breast Neoplasms
1
2016
2411
0.050
Why?
Vincristine
1
2023
148
0.050
Why?
Administration, Oral
1
2025
867
0.050
Why?
Infant, Newborn
3
2019
6449
0.050
Why?
Chromosomes, Human, Pair 3
1
2022
43
0.050
Why?
HLA-B Antigens
1
2022
58
0.050
Why?
Chromosome Inversion
1
2022
20
0.050
Why?
Animals
4
2023
38030
0.050
Why?
Drug Therapy, Combination
1
2025
1034
0.050
Why?
Prospective Studies
2
2025
8087
0.040
Why?
Sirolimus
1
2023
282
0.040
Why?
Fetal Hemoglobin
1
2021
8
0.040
Why?
United States
3
2026
16041
0.040
Why?
Glucocorticoids
1
2025
536
0.040
Why?
Eukaryotic Initiation Factors
1
2021
12
0.040
Why?
Liver Diseases
1
2024
298
0.040
Why?
Histocompatibility Antigens Class I
1
2022
207
0.040
Why?
Sensitivity and Specificity
1
2025
1992
0.040
Why?
Telomere
1
2024
300
0.040
Why?
Unrelated Donors
1
2020
39
0.040
Why?
Venous Thromboembolism
1
2024
330
0.040
Why?
Hemorrhage
1
2025
824
0.040
Why?
Mice
2
2022
18266
0.040
Why?
Bone Marrow
1
2021
308
0.040
Why?
Zebrafish Proteins
1
2023
314
0.040
Why?
Tacrolimus
1
2021
192
0.040
Why?
Horses
1
2021
229
0.040
Why?
Incidence
1
2026
2910
0.040
Why?
Genotype
1
2024
1866
0.040
Why?
Alleles
1
2022
900
0.040
Why?
Ribosomes
1
2021
195
0.040
Why?
Genetic Variation
1
2024
992
0.040
Why?
Anticoagulants
1
2024
743
0.040
Why?
Abdominal Cavity
1
2018
5
0.040
Why?
Phosphorylation
1
2023
1717
0.030
Why?
Extravasation of Diagnostic and Therapeutic Materials
1
2018
20
0.030
Why?
Diagnosis, Differential
1
2021
1500
0.030
Why?
Ultrasonography, Interventional
1
2018
163
0.030
Why?
Polymorphism, Single Nucleotide
1
2024
2228
0.030
Why?
Tumor Suppressor Protein p53
1
2021
530
0.030
Why?
Endothelial Cells
1
2023
876
0.030
Why?
Emulsions
1
2016
58
0.030
Why?
Feasibility Studies
1
2020
1125
0.030
Why?
Genetic Predisposition to Disease
1
2024
2455
0.030
Why?
Mutation
2
2021
4082
0.030
Why?
DNA-Binding Proteins
1
2022
1467
0.030
Why?
Polymerase Chain Reaction
1
2016
1030
0.020
Why?
Quality of Life
1
2025
3187
0.020
Why?
Base Sequence
1
2016
2119
0.020
Why?
Uroporphyrinogen III Synthetase
1
2011
1
0.020
Why?
Photosensitivity Disorders
1
2011
8
0.020
Why?
Cohort Studies
1
2022
6045
0.020
Why?
Cell Line
1
2016
2809
0.020
Why?
Homozygote
1
2011
196
0.020
Why?
Colorado
1
2021
4588
0.020
Why?
Fatal Outcome
1
2011
302
0.020
Why?
Lung Injury
1
2011
262
0.020
Why?
Magnetic Resonance Imaging
1
2018
3917
0.010
Why?
Hypertension, Pulmonary
1
2011
1957
0.010
Why?
Nakano's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)